We are live on ! Find out more
SOPH icon

SOPHiA GENETICS

32 hedge funds and large institutions have $262M invested in SOPHiA GENETICS in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 7

7% more funds holding

Funds holding: 3032 (+2)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0.27% less ownership

Funds ownership: 29.42%29.15% (-0.27%)

20% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 10

21% less capital invested

Capital invested by funds: $331M → $262M (-$69M)

Holders
32
Holders Change
+2
Holders Change %
+6.67%
% of All Funds
0.49%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
9
Increased
8
Reduced
10
Closed
7
Calls
Puts
Net Calls
Net Calls Change

SOPH Hedge Fund Activity: Q4 2021 in Review

32 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in SOPHiA GENETICS (SOPH) for Q4 2021, worth a combined $262M — down 21% from $331M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new SOPH positions and 7 closed out — a net gain of 2 holders — while 8 added to existing stakes and 10 trimmed.

The largest buyer was Jennison Associates, adding an estimated $11.7M. The largest seller was Pura Vida Investments, exiting entirely with an estimated $7.89M sold.

  • 32 institutional investors held SOPHiA GENETICS (SOPH) as of Q4 2021, up from 30 in Q3 2021.
  • Funds reported $262M of SOPHiA GENETICS stock for Q4 2021, down 21% quarter-over-quarter.
  • 9 funds opened new SOPHiA GENETICS positions in Q4 2021 and 7 closed out, a net change of +2 holders.
  • The largest SOPHiA GENETICS buyer in Q4 2021 was Jennison Associates, an estimated $11.7M added.
  • The largest SOPHiA GENETICS seller in Q4 2021 was Pura Vida Investments, an estimated $7.89M sold.

Based on aggregated 13F filings for Q4 2021.